The U.S. Food and Drug Administration’s vaccine advisory panel on Tuesday voted 22 – 0 to authorize Moderna’s COVID-19 vaccines for children ages 6 to 11 and 12 to 17 despite the lack of short- and long-term safety data and no evidence children are at risk of serious illness. The U.S. Food and Drug Administration’s (FDA) vaccine advisory panel today voted unanimously to recommend Moderna’s COVID-19 vaccine … Continue reading Breaking News: FDA Panel Recommends Moderna Two-Dose COVID Vaccine for Kids Ages 6 to 17 Despite Serious Safety Concerns